© 1999 American Heart Association, Inc.
Original Contribution |
Mouse Model of a Familial Hypertrophic Cardiomyopathy Mutation in 
-Tropomyosin Manifests Cardiac Dysfunction
From the Department of Molecular Genetics, Biochemistry and Microbiology (M.M., K.P., P.R., D.F.W.), Department of Internal Medicine, Division of Cardiology (B.H.), Department of Pharmacology and Cell Biophysics (I.L.G.), Department of Pathology and Laboratory Medicine (G.P.B.), University of Cincinnati College of Medicine, Cincinnati, Ohio; and the Department of Physiology and Biophysics (B.W., C.E., R.J.S.), University of Illinois, College of Medicine, Chicago. The current affiliation for M.M. is the Department of Medical Physiology, Texas A&M University Health Science Center, College Station, Tex.
Correspondence to David F. Wieczorek, Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0524. E-mail david.wieczorek{at}uc.edu
Abstract—To investigate the
functional consequences of a tropomyosin (TM) mutation associated with
familial hypertrophic cardiomyopathy (FHC), we
generated transgenic mice that express mutant 
-TM in the adult
heart. The missense mutation, which results in the substitution of
asparagine for aspartic acid at amino acid position 175, occurs in a
troponin T binding region of TM. S1 nuclease mapping and Western blot
analyses demonstrate that increased expression of the -TM
175 transgene in different lines causes a concomitant decrease in
levels of endogenous -TM mRNA and protein expression. In
vivo physiological analyses show a severe
impairment of both contractility and relaxation in
hearts of the FHC mice, with a significant change in left
ventricular fractional shortening. Myofilaments that
contain -TM 175 demonstrate an increased activation of the thin
filament through enhanced Ca2+ sensitivity of steady-state
force. Histological analyses show patchy areas
of mild ventricular myocyte disorganization and
hypertrophy, with occasional thrombi formation in the left
atria. Thus, the FHC -TM transgenic mouse can serve as a model
system for the examination of pathological and
physiological alterations imparted through aberrant
TM isoforms.
Key Words: tropomyosin • cardiomyopathy • troponin • hypertrophy
This article has been cited by other articles:
 |
|
 |
|
  S. Morimoto Sarcomeric proteins and inherited cardiomyopathies Cardiovasc Res, March 1, 2008; 77(4): 659 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Schevzov, T. Fath, B. Vrhovski, N. Vlahovich, S. Rajan, J. Hook, J. E. Joya, F. Lemckert, F. Puttur, J. J.-C. Lin, et al. Divergent Regulation of the Sarcomere and the Cytoskeleton J. Biol. Chem., January 4, 2008; 283(1): 275 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Houle, A. Poirier, J. Dumaresq, and J. Huot DAP kinase mediates the phosphorylation of tropomyosin-1 downstream of the ERK pathway, which regulates the formation of stress fibers in response to oxidative stress J. Cell Sci., October 15, 2007; 120(20): 3666 - 3677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Jagatheesan, S. Rajan, N. Petrashevskaya, A. Schwartz, G. Boivin, G. M. Arteaga, R. John Solaro, S. B. Liggett, and D. F. Wieczorek Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H949 - H958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rajan, R. P.H. Ahmed, G. Jagatheesan, N. Petrashevskaya, G. P. Boivin, D. Urboniene, G. M. Arteaga, B. M. Wolska, R. J. Solaro, S. B. Liggett, et al. Dilated Cardiomyopathy Mutant Tropomyosin Mice Develop Cardiac Dysfunction With Significantly Decreased Fractional Shortening and Myofilament Calcium Sensitivity Circ. Res., July 20, 2007; 101(2): 205 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rajan, S. S. Williams, G. Jagatheesan, R. P. H. Ahmed, G. Fuller-Bicer, A. Schwartz, B. J. Aronow, and D. F. Wieczorek Microarray analysis of gene expression during early stages of mild and severe cardiac hypertrophy Physiol Genomics, November 21, 2006; 27(3): 309 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Gaffin, K. Gokulan, J. C. Sacchettini, T. E. Hewett, R. Klevitsky, J. Robbins, V. Sarin, D. C. Zawieja, G. A. Meininger, and M. Muthuchamy Changes in end-to-end interactions of tropomyosin affect mouse cardiac muscle dynamics Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H552 - H563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sipola, K. Lauerma, P. Jaaskelainen, M. Laakso, K. Peuhkurinen, H. Manninen, H. J. Aronen, and J. Kuusisto Cine MR Imaging of Myocardial Contractile Impairment in Patients with Hypertrophic Cardiomyopathy Attributable to Asp175Asn Mutation in the {alpha}-Tropomyosin Gene Radiology, September 1, 2005; 236(3): 815 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Szczesna-Cordary, G. Guzman, J. Zhao, O. Hernandez, J. Wei, and Z. Diaz-Perez The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice J. Cell Sci., August 15, 2005; 118(16): 3675 - 3683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kremneva, S. Boussouf, O. Nikolaeva, R. Maytum, M. A. Geeves, and D. I. Levitsky Effects of Two Familial Hypertrophic Cardiomyopathy Mutations in {alpha}-Tropomyosin, Asp175Asn and Glu180Gly, on the Thermal Unfolding of Actin-Bound Tropomyosin Biophys. J., December 1, 2004; 87(6): 3922 - 3933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Jagatheesan, S. Rajan, N. Petrashevskaya, A. Schwartz, G. Boivin, G. Arteaga, P. P. de Tombe, R. J. Solaro, and D. F. Wieczorek Physiological significance of troponin T binding domains in striated muscle tropomyosin Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1484 - H1494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wernicke, C. Thiel, C. M. Duja-Isac, K. V. Essin, M. Spindler, D. J. R. Nunez, R. Plehm, N. Wessel, A. Hammes, R.-J. Edwards, et al. {alpha}-Tropomyosin mutations Asp175Asn and Glu180Gly affect cardiac function in transgenic rats in different ways Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R685 - R695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Kee, G. Schevzov, V. Nair-Shalliker, C. S. Robinson, B. Vrhovski, M. Ghoddusi, M. R. Qiu, J. J.-C. Lin, R. Weinberger, P. W. Gunning, et al. Sorting of a nonmuscle tropomyosin to a novel cytoskeletal compartment in skeletal muscle results in muscular dystrophy J. Cell Biol., August 30, 2004; 166(5): 685 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Gaffin, K. Gokulan, J. C. Sacchettini, T. Hewett, R. Klevitsky, J. Robbins, and M. Muthuchamy Charged residue changes in the carboxy-terminus of {alpha}-tropomyosin alter mouse cardiac muscle contractility J. Physiol., April 15, 2004; 556(2): 531 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Jagatheesan, S. Rajan, N. Petrashevskaya, A. Schwartz, G. Boivin, S. Vahebi, P. DeTombe, R. J. Solaro, E. Labitzke, G. Hilliard, et al. Functional Importance of the Carboxyl-terminal Region of Striated Muscle Tropomyosin J. Biol. Chem., June 13, 2003; 278(25): 23204 - 23211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Metzger, D. E. Michele, E. M. Rust, A. R. Borton, and M. V. Westfall Sarcomere Thin Filament Regulatory Isoforms. EVIDENCE OF A DOMINANT EFFECT OF SLOW SKELETAL TROPONIN I ON CARDIAC CONTRACTION J. Biol. Chem., April 4, 2003; 278(15): 13118 - 13123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fatkin and R. M. Graham Molecular Mechanisms of Inherited Cardiomyopathies Physiol Rev, October 1, 2002; 82(4): 945 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Murphy Troponin I: In Sickness and In Health--and Normal Development Circ. Res., September 20, 2002; 91(6): 449 - 450. [Full Text] [PDF]
|
|
|
|
|
|
D. E. Michele, C. A. Gomez, K. E. Hong, M. V. Westfall, and J. M. Metzger Cardiac Dysfunction in Hypertrophic Cardiomyopathy Mutant Tropomyosin Mice Is Transgene-Dependent, Hypertrophy-Independent, and Improved by {beta}-Blockade Circ. Res., August 9, 2002; 91(3): 255 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Michele, P. Coutu, and J. M. Metzger Divergent abnormal muscle relaxation by hypertrophic cardiomyopathy and nemaline myopathy mutant tropomyosins Physiol Genomics, May 10, 2002; 9(2): 103 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Wu, J. Hagaman, S. Kim, R. L. Reddick, and N. Maeda Aortic Constriction Exacerbates Atherosclerosis and Induces Cardiac Dysfunction in Mice Lacking Apolipoprotein E Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 469 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Patel, D. P. Fitzsimons, S. H. Buck, M. Muthuchamy, D. F. Wieczorek, and R. L. Moss PKA accelerates rate of force development in murine skinned myocardium expressing {alpha}- or {beta}-tropomyosin Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2732 - H2739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. M. Hernandez, P. R. Housmans, and J. D. Potter Plasticity in Skeletal, Cardiac, and Smooth Muscle: Invited Review: Pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation J Appl Physiol, March 1, 2001; 90(3): 1125 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. MOGENSEN, P. S. ANDERSEN, U. STEFFENSEN, M. CHRISTIANSEN, H. EGEBLAD, N. GREGERSEN, and A. D. BØRGLUM Development and application of linkage analysis in genetic diagnosis of familial hypertrophic cardiomyopathy J. Med. Genet., March 1, 2001; 38(3): 193 - 198. [Full Text]
|
|
|
|
 |
|
 A. Karibe, L. S. Tobacman, J. Strand, C. Butters, N. Back, L. L. Bachinski, A. E. Arai, A. Ortiz, R. Roberts, E. Homsher, et al. Hypertrophic Cardiomyopathy Caused by a Novel {{alpha}}-Tropomyosin Mutation (V95A) Is Associated With Mild Cardiac Phenotype, Abnormal Calcium Binding to Troponin, Abnormal Myosin Cycling, and Poor Prognosis Circulation, January 2, 2001; 103(1): 65 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Evans, J. R. Pena, R. M. Phillips, M. Muthuchamy, D. F. Wieczorek, R. J. Solaro, and B. M. Wolska Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2414 - H2423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Prabhakar, G. P. Boivin, B. Hoit, and D. F. Wieczorek Rescue of High Expression beta -Tropomyosin Transgenic Mice by 5-Propyl-2-thiouracil. REGULATING THE alpha -MYOSIN HEAVY CHAIN PROMOTER J. Biol. Chem., October 8, 1999; 274(41): 29558 - 29563. [Abstract] [Full Text] [PDF]
|
|